12:14 PM EST - Pharmala Biotech Holdings Inc : Announces that it has signed an agreement with CCrest Laboratories Inc. which will allow for its GMP MDMA to be delivered to customers in Canada and around the world. CCrest is a cGMP research and testing facility operating under Health Canada Controlled Substances Dealer's and Drug Establishment licenses. Pharmala Biotech Holdings Inc
shares C.MDMA are trading unchanged at $0.03.
